Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Apr 1;139(4):571-578.
doi: 10.1097/AOG.0000000000004718. Epub 2022 Mar 10.

Educational Multimedia Tool Compared With Routine Care for the Uptake of Postpartum Long-Acting Reversible Contraception in Individuals With High-Risk Pregnancies: A Randomized Controlled Trial

Emma J Qureshey  1 , Suneet P Chauhan, Stephen M Wagner, Oliver Batiste, Han-Yang Chen, Sunbola Ashimi, Patti Jayne Ross, Sean C Blackwell, Baha M Sibai
Affiliations
Randomized Controlled Trial

Educational Multimedia Tool Compared With Routine Care for the Uptake of Postpartum Long-Acting Reversible Contraception in Individuals With High-Risk Pregnancies: A Randomized Controlled Trial

Emma J Qureshey et al. Obstet Gynecol. .

Abstract

Objective: To assess whether an intervention with a multimedia educational tool, compared with routine care, would increase the use of long-acting reversible contraceptives (LARC) at 12 weeks postpartum in individuals with high-risk pregnancies.

Methods: In this single-center randomized trial, we assigned individuals aged 13-50 years with high-risk pregnancies to either a multimedia educational tool or routine care. Participants were included during pregnancy through postpartum day 1. Those randomized to the multimedia educational tool (MET) group were provided a tablet with the preloaded 3-5-minute multimedia presentation (https://prezi.com/view/jpFrXaPnnxuqRkcI3A4a/), which was viewed without the presence of research staff and resent by secure email every 4 weeks if undelivered. The primary outcome was uptake of LARC (implant or intrauterine device) within 12 weeks of delivery. The secondary outcomes included overall use of any method of contraception and composite maternal and neonatal adverse outcomes. A priori estimates indicated that 380 participants were needed to detect a 40% difference in use of LARC (baseline 40%; alpha=0.05, power=0.8, assumed loss to follow-up 20%). Relative risk (RR) and number needed to treat (NNT), along with 95% CIs, were calculated.

Results: From July 2020 through December 2020, 536 persons were screened and 380 randomized as follows: 190 for the multimedia educational tool and 190 for routine care. Demographic characteristics were similar between groups. The primary outcome-available for more than 90% of participants-was higher in the MET group (32.4%) than in the routine care (RC) group (20.9%) (RR 1.55; 95% CI 1.09-2.21; NNT nine, with 95% CI 5-42). Overall use of contraception was also higher in the MET group than in the RC group (RR 1.16; 95% CI 1.03-1.32).

Conclusion: Among individuals with high-risk pregnancies, compared with routine care, use of a multimedia-based educational tool increased the uptake of postpartum LARC by 55%.

Clinical trial registration: ClinicalTrials.gov, NCT04291040.

Funding source: Funded in part by Investigator-Initiated studies of Organon.

PubMed Disclaimer

Conflict of interest statement

Financial Disclosure Patti Jayne Ross disclosed that she has been a Nexplanon trainer for several years and has a relationship with Organon. The other authors did not report any potential conflicts of interest.

References

    1. Peipert JF, Madden T, Allsworth JE, Secura GM. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol 2012;120:1291–7. doi: 10.1097/aog.0b013e318273eb56 - DOI
    1. Immediate postpartum long-acting reversible contraception. Committee Opinion No. 670. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e32–7. doi: 10.1097/aog.00000000001587 - DOI
    1. Immediate postpartum long-acting reversible contraception for women at high risk for medical complications. SMFM Consult Series #48. Society for Maternal-Fetal Medicine. Am J Obstet Gynecol 2019;220:B2–12. doi: 10.1016/j.ajog.2019.02,011 - DOI
    1. Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008;78:143–8. doi: 10.1016/j.contraception.2008.03.003 - DOI
    1. Tocce KM, Sheeder JL, Teal SB. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference? Am J Obstet Gynecol 2012;206:481.e1–7. doi: 10.1016/j.ajog.2012.04.015 - DOI

Publication types

Substances

Associated data